HARVARD BIOSCIENCE, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
HARVARD BIOSCIENCE, INC. (HBIO) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $380.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $380.00K, a 19.49% decline year-over-year.
- HARVARD BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $257.00K, a 57.17% decline year-over-year.
- HARVARD BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $459.00K, a 52.24% decline year-over-year.
- HARVARD BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $324.00K, a 69.23% decline year-over-year.
- HARVARD BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $1.85M, a 57.26% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $4.34M, a 13.20% decline from fiscal 2023.
- HARVARD BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $5.00M, a 13.35% increase from fiscal 2022.
- HARVARD BIOSCIENCE, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $4.41M, a 5.80% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $380.00K 10-Q · filed 2026-08-11 | $637.00K 10-Q · filed 2026-08-11 | $1.10M derived: sum of 3 quarters · filed 2026-08-11 | $1.42M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $257.00K 10-Q · filed 2026-05-12 | $716.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.04M derived: sum of 3 quarters · filed 2026-05-12 | $1.51M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $783.00K derived: sum of 2 quarters · filed 2026-03-13 | $1.25M derived: sum of 3 quarters · filed 2026-08-11 | $1.85M 10-K · filed 2026-03-13 |
| 2025-09-30 | $324.00K 10-Q · filed 2025-11-06 | $796.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.40M 10-Q · filed 2025-11-06 | $2.36M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $472.00K 10-Q · filed 2026-08-11 | $1.07M 10-Q · filed 2026-08-11 | $2.03M derived: sum of 3 quarters · filed 2026-08-11 | $3.09M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $600.00K 10-Q · filed 2026-05-12 | $1.56M derived: sum of 2 quarters · filed 2026-05-12 | $2.61M derived: sum of 3 quarters · filed 2026-05-12 | $3.89M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $961.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $2.01M derived: sum of 2 quarters · filed 2026-03-13 | $3.29M derived: sum of 3 quarters · filed 2026-03-13 | $4.34M 10-K · filed 2026-03-13 |
| 2024-09-30 | $1.05M 10-Q · filed 2025-11-06 | $2.33M derived: sum of 2 quarters · filed 2025-11-06 | $3.38M 10-Q · filed 2025-11-06 | $4.76M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.28M 10-Q · filed 2025-08-11 | $2.33M 10-Q · filed 2025-08-11 | $3.71M derived: sum of 3 quarters · filed 2025-08-11 | $5.07M derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $1.05M 10-Q · filed 2025-05-12 | $2.43M derived: sum of 2 quarters · filed 2025-05-12 | $3.79M derived: sum of 3 quarters · filed 2025-05-12 | $4.89M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $2.75M derived: sum of 2 quarters · filed 2025-03-14 | $3.85M derived: sum of 3 quarters · filed 2025-03-14 | $5.00M 10-K · filed 2025-03-14 |
| 2023-09-30 | $1.36M 10-Q · filed 2024-11-08 | $2.46M derived: sum of 2 quarters · filed 2024-11-08 | $3.62M 10-Q · filed 2024-11-08 | $4.63M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $1.10M 10-Q · filed 2024-08-08 | $2.25M 10-Q · filed 2024-08-08 | $3.27M derived: sum of 3 quarters · filed 2024-08-08 | $4.40M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.15M 10-Q · filed 2024-05-07 | $2.16M derived: sum of 2 quarters · filed 2024-05-07 | $3.30M derived: sum of 3 quarters · filed 2024-05-07 | $4.54M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $2.15M derived: sum of 2 quarters · filed 2024-03-07 | $3.39M derived: sum of 3 quarters · filed 2024-03-07 | $4.41M 10-K · filed 2024-03-07 |
| 2022-09-30 | $1.14M 10-Q · filed 2023-11-07 | $2.38M derived: sum of 2 quarters · filed 2023-11-07 | $3.40M 10-Q · filed 2023-11-07 | $4.43M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $1.24M 10-Q · filed 2023-08-08 | $2.26M 10-Q · filed 2023-08-08 | $3.29M derived: sum of 3 quarters · filed 2023-08-08 | $4.30M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.02M 10-Q · filed 2022-05-04 | $2.06M derived: sum of 2 quarters · filed 2023-03-09 | $3.06M derived: sum of 3 quarters · filed 2023-03-09 | $4.22M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $2.04M derived: sum of 2 quarters · filed 2023-03-09 | $3.20M derived: sum of 3 quarters · filed 2023-03-09 | $4.17M 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.00M 10-Q · filed 2022-11-09 | $2.17M derived: sum of 2 quarters · filed 2022-11-09 | $3.14M 10-Q · filed 2022-11-09 | $4.14M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $1.16M 10-Q · filed 2022-08-04 | $2.13M 10-Q · filed 2022-08-04 | $3.14M derived: sum of 3 quarters · filed 2022-08-04 | $4.22M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $968.00K 10-Q · filed 2022-05-04 | $1.97M derived: sum of 2 quarters · filed 2022-05-04 | $3.05M derived: sum of 3 quarters · filed 2022-05-04 | $3.82M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $2.08M derived: sum of 2 quarters · filed 2022-03-11 | $2.85M derived: sum of 3 quarters · filed 2022-03-11 | $3.65M 10-K · filed 2022-03-11 |
| 2020-09-30 | $1.08M 10-Q · filed 2021-11-05 | $1.85M derived: sum of 2 quarters · filed 2021-11-05 | $2.64M 10-Q · filed 2021-11-05 | $3.48M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $769.00K 10-Q · filed 2021-08-06 | $1.56M 10-Q · filed 2021-08-06 | $2.40M derived: sum of 3 quarters · filed 2021-08-06 | $3.39M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $793.00K 10-Q · filed 2021-05-07 | $1.63M derived: sum of 2 quarters · filed 2021-05-07 | $2.62M derived: sum of 3 quarters · filed 2021-05-07 | $3.24M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $841.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-03-17 | $1.83M derived: sum of 2 quarters · filed 2021-03-17 | $2.44M derived: sum of 3 quarters · filed 2021-03-17 | $3.03M 10-K/A · filed 2021-03-17 |
| 2019-09-30 | $987.00K 10-Q · filed 2020-11-06 | $1.60M derived: sum of 2 quarters · filed 2020-11-06 | $2.19M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $615.00K 10-Q · filed 2020-08-10 | $1.21M 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $591.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $3.04M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |